| Literature DB >> 36016933 |
Wei Liu1, Wei Qiu2, Zhendong Huang2, Kaiying Zhang2, Keke Wu3, Ke Deng4, Yuanting Chen2, Ruiming Guo2, Buling Wu1,2, Ting Chen2, Fuchun Fang2.
Abstract
Recently, there are many researches on signature molecules of periodontitis derived from different periodontal tissues to determine the disease occurrence and development, and deepen the understanding of this complex disease. Among them, a variety of omics techniques have been utilized to analyze periodontitis pathology and progression. However, few accurate signature molecules are known and available. Herein, we aimed to screened and identified signature molecules suitable for distinguishing periodontitis patients using machine learning models by integrated analysis of TMT proteomics and transcriptomics with the purpose of finding novel prediction or diagnosis targets. Differential protein profiles, functional enrichment analysis, and protein-protein interaction network analysis were conducted based on TMT proteomics of 15 gingival tissues from healthy and periodontitis patients. DEPs correlating with periodontitis were screened using LASSO regression. We constructed a new diagnostic model using an artificial neural network (ANN) and verified its efficacy based on periodontitis transcriptomics datasets (GSE10334 and GSE16134). Western blotting validated expression levels of hub DEPs. TMT proteomics revealed 5658 proteins and 115 DEPs, and the 115 DEPs are closely related to inflammation and immune activity. Nine hub DEPs were screened by LASSO, and the ANN model distinguished healthy from periodontitis patients. The model showed satisfactory classification ability for both training (AUC=0.972) and validation (AUC=0.881) cohorts by ROC analysis. Expression levels of the 9 hub DEPs were validated and consistent with TMT proteomics quantitation. Our work reveals that nine hub DEPs in gingival tissues are closely related to the occurrence and progression of periodontitis and are potential signature molecules involved in periodontitis.Entities:
Keywords: TMT proteomics; artificial neural network; inflammation and immune response; periodontitis; signature proteins; transcriptomics
Mesh:
Substances:
Year: 2022 PMID: 36016933 PMCID: PMC9397367 DOI: 10.3389/fimmu.2022.963123
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 8.786
The basic information of the 15 individuals included in proteomic analysis.
| Sample | Age | Gender | Diagnosis | Smoking | Tooth loss | Treatment stage | Full-mouth | Site-specific | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean PPD(range; mm) | Mean CAL(range; mm) | BOP(%) | Mean PPD(range; mm) | Mean CAL(range; mm) | BOP(+/-) | ||||||||
| P | 1 | 48 | Female | Periodontitis | No | 0 | Before initial therapy | 5.15 (3–10) | 5.24 (3–11) | 57.14 | 8.40 (6–10) | 8.50 (6-10) | + |
| 2 | 48 | Male | Periodontitis | No | 0 | Before initial therapy | 6.95 (3-10) | 7.39 (3-10) | 75.00 | 8.50 (7-9) | 8.00 (7-9) | + | |
| 3 | 41 | Male | Periodontitis | No | 1 | Before initial therapy | 5.31 (2-9) | 5.54 (2-11) | 82.14 | 8.20 (7-10) | 8.8 (7-10) | + | |
| 4 | 55 | Female | Periodontitis | No | 1 | Before initial therapy | 6.81 (4-10) | 7.72 (4-11) | 85.71 | 9.00 (8-10) | 9.33 (9-10) | + | |
| 5 | 58 | Male | Periodontitis | No | 6 | Before initial therapy | 5.35 (3-10) | 5.81 (3-11) | 59.52 | 7.75 (6-9) | 8.25 (7-9) | + | |
| 6 | 38 | Female | Periodontitis | No | 0 | Before initial therapy | 3.42 (2-5) | 3.83 (0-4) | 39.88 | 4.00 (3-5) | 3.50 (3-4) | + | |
| 7 | 44 | Male | Periodontitis | No | 0 | Before initial therapy | 3.55 (2-5) | 3.75 (0-4) | 36.31 | 4.50 (3-5) | 3.60 (3-4) | + | |
| 8 | 41 | Male | Periodontitis | No | 0 | Before initial therapy | 3.67 (3-6) | 3.80 (0-4) | 26.19 | 4.80 (4-5) | 3.60 (3-4) | + | |
| 9 | 58 | Male | Periodontitis | No | 0 | Before initial therapy | 3.49 (2-6) | 3.66 (0-4) | 28.57 | 4.25 (4-5) | 3.17 (2-4) | + | |
| 10 | 35 | Female | Periodontitis | No | 0 | Before initial therapy | 3.27 (2-5) | 3.41 (0-4) | 38.69 | 4.50 (4-5) | 3.75 (3-4) | + | |
| H | 1 | 34 | Female | Healthy | No | 0 | During CLP | 2.02 (1-4) | 0.89 (0-2) | 4.17 | 2.75 (2-3) | 0 | – |
| 2 | 43 | Female | Healthy | No | 0 | During CLP | 2.10 (1-3) | 0.30 (0-1) | 4.76 | 2.67 (2-3) | 0 | – | |
| 3 | 37 | Male | Healthy | No | 0 | During CLP | 2.05 (1-3) | 0.48 (0-1) | 5.95 | 2.20 (1-3) | 0 | – | |
| 4 | 38 | Male | Healthy | No | 0 | During CLP | 2.08 (1-3) | 0.71 (0-1) | 6.54 | 2.00 (1-3) | 0 | – | |
| 5 | 34 | Male | Healthy | No | 0 | During CLP | 2.01 (1-3) | 0.58 (0-2) | 7.74 | 2.25 (2-3) | 0 | – | |
P, Periodontitis; H, Healthy individuals; CLP, crown lengthening procedure; PPD, periodontal probing depth; CAL, clinical attachment loss; BOP, bleeding on probing.
Figure 1Characteristics of gingival tissues from healthy individuals and periodontitis patients and a schematic overview of the quantitative TMT proteomics workflow. (A, B) Collection and H&E staining of gingival tissues from healthy individuals (A) and periodontitis patients (B). (C) Flow diagram of TMT-based quantitative proteomics.
Figure 2DEPs were identified in gingival tissues from periodontitis versus healthy tissues. (A) Volcano plot displaying DEPs in gingival tissues. Green dots indicate down-regulated DEPs, and red dots indicate up-regulated DEPs. (B) Heatmap of the top 30 DEPs. Red cells represent up-regulated DEPs, and blue cells represent down-regulated DEPs. (C) Metascape enrichment network visualization shows the intra-cluster and inter-cluster similarities of enriched terms for the 115. Nodes of the same color belong to the same cluster. Terms with similarity scores > 0.3 are linked by edges, and nodes in the same condensed network are colored with p values. (D, E) Circos plots represent significantly enriched GO terms (D) and pathways (E) associated with DEPs.
Figure 3PPI network and subnetwork of DEPs. (A) PPI network of 115 DEPs constructed using STRING. (B) Functional sub-network analysis of the PPI network.
Figure 4Screening of hub DEPs using LASSO regression analysis. (A) Coefficients of nine DEPs were selected by the lambda with the minimum binomial deviance marked by the black dashed line (ln(lambda) = -4.88). (B) The LASSO binomial model fitting process. Each curve represents a variable. (C) Coefficient values for each of the nine selected proteins from LASSO regression. A positive coefficient for a protein signature within its class indicates that elevated expression of this protein increases the probability of a specimen belonging to its tissue type. (D) Circos plot shows the correlations between the nine hub DEPs according to the protein expression levels. Green connecting lines represent negative correlations, and red lines represent positive correlations.
Figure 5Dataset preprocessing and differential expression analysis of 9 hub DEGs. (A) The PCA plot displays removal batch effect between GSE10334 and GSE16134 cohorts. (B) Expression profile of the 9 hub DEGs in the “pooled” dataset. (C) Expression of 9 hub DEGs correlated with the infiltration levels of various immune cells in periodontitis. The size and color of the pie chart were related to the correlation for the interaction of immune cells. The line color is related to the degree of correlation, and line size represents the p value.
Figure 6Establishment and validation of artificial neural networks. (A) Results of neural network visualization based on the expression of nine hub genes. Linewidths of connectors represent the weights: the wider the line is, the heavier the weight is. O1: healthy group; O2: periodontitis group. (B, C) ROC curves for the 9 hub DEGs in the training cohort (B) and validation cohort (C) by the five-time cross-validation model. AUC, area under the curve.
Figure 7Validation results of western blotting. (A) Validation of the 9 hub DEPs by western blotting. GAPDH was used as a loading control. (B) Quantitative results of western blotting from Fig 7A. Data are represented as the mean ± SD. *p < 0.05.